Specification
Description
Glymidine sodium is a sulfonamide hypoglycemic agent which stimulates insulin secretion.
Synonyms
BS 717; Glycanol; Glycodiazin; Glycodiazine; Glycodiazine sodium; Glyconormal; Glymidine; Glymidine sodium; Glymidine sodium salt; Gondafon; Lycanol; Redul; Redul IF; Redul sodium; SH 717
IUPAC Name
Benzenesulfonamide, N-(5-(2-methoxyethoxy)-2-pyrimidinyl)-, sodium salt
Canonical SMILES
O=S(C1=CC=CC=C1)([N-]C2=NC=C(OCCOC)C=N2)=O.[Na+]
InChI
InChI=1S/C13H14N3O4S.Na/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12;/h2-6,9-10H,7-8H2,1H3;/q-1;+1
InChI Key
NUQDEHHKOXSIEA-UHFFFAOYSA-N
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Storage
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Alternative CAS
339-44-6 (free acid); 3459-20-9 (sodium)
Biological Target
Glymidine sodium is an active antidiabetic that inhibits the glucose formation and supresses the elevated pyruvate oxidation, which results from the inhibition of endogenous lipid mobilization.
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 47.13; H, 4.26; N, 12.68; Na, 6.94; O, 19.32; S, 9.68
HS Tariff Code
2934.99.03.00
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).